Form 8-K - Current report:
SEC Accession No. 0001493152-24-014035
Filing Date
2024-04-09
Accepted
2024-04-09 12:05:30
Documents
13
Period of Report
2024-03-22
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 29072
  Complete submission text file 0001493152-24-014035.txt   193607

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE clcs-20240322.xsd EX-101.SCH 3024
3 XBRL LABEL FILE clcs-20240322_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE clcs-20240322_pre.xml EX-101.PRE 22365
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3168
Mailing Address 57 WEST 57TH STREET SUITE 400 NEW YORK NY 10019
Business Address 57 WEST 57TH STREET SUITE 400 NEW YORK NY 10019 646-612-7554
Cell Source, Inc. (Filer) CIK: 0001569340 (see all company filings)

EIN.: 320379665 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-55413 | Film No.: 24831721
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)